Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD -1.92%89 Equity-to-Asset is 0.71 as of Jun. 2026, which is 3% below its 10-year median of 0.73. GuruFocus rates VMD with a GF Score™ of 89/100 and a GF Value™ of $10.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 61.69% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Viemed Healthcare's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $144.0 Mil. Viemed Healthcare's Total Assets for the quarter that ended in Jun. 2026 was $204.2 Mil.
Therefore, Viemed Healthcare's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.71.
The historical rank and industry rank for Viemed Healthcare's Equity-to-Asset or its related term are showing as below:
VMD'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52 Med: 0.73 Max: 0.83
Current: 0.71
During the past 10 years, the highest Equity to Asset Ratio of Viemed Healthcare was 0.83. The lowest was 0.52. And the median was 0.73.
VMD's Equity-to-Asset is ranked better than 61.69% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs VMD: 0.71
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Viemed Healthcare Equity-to-Asset Related Terms
Viemed Healthcare Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Viemed Healthcare's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare (VMD) has a Equity-to-Asset of 0.71 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Viemed Healthcare and its competitors. This is near median its historical median of 0.73. Over the past decade, Viemed Healthcare's Equity-to-Asset has ranged from 0.52 to 0.83. According to the industry distribution chart, Viemed Healthcare ranks #326 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 38.3%.
Is Viemed Healthcare's Equity-to-Asset too high?
Viemed Healthcare's current Equity-to-Asset of 0.71 is near median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 0.83. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Viemed Healthcare's value of 0.71 is 10.9% above this industry median. Based on the distribution chart, Viemed Healthcare ranks #326 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Viemed Healthcare has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Equity-to-Asset compare to OFIX and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #326 out of 851 companies for Equity-to-Asset. This puts Viemed Healthcare in the upper half of its industry. The industry median Equity-to-Asset is 0.64. Viemed Healthcare's value of 0.71 is 10.9% above this benchmark. Historically, Viemed Healthcare's own Equity-to-Asset has ranged from 0.52 to 0.83 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 0.64, Viemed Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current Equity-to-Asset of 0.71 is 10.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current Equity-to-Asset is 0.71, which is near median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.97, compared to a current price of $8.93 — trading 18.6% below its estimated fair value. The current Equity-to-Asset is 0.71, which is near median its 10-year median of 0.73 and 10.9% above the Medical Devices & Instruments industry median of 0.64. Viemed Healthcare's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current Equity-to-Asset is 0.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be undervalued.
The current stock price of $8.93 is trading 18.6% below its estimated GF Value™ of $10.97.
GuruFocus considers Viemed Healthcare to be Modestly Undervalued.
Key valuation signals for VMD:
Equity-to-Asset: 0.71 (near median its 10-year median of 0.73)
GF Value™: $10.97 vs. price of $8.93 (18.6% below fair value)
Industry Position: 10.9% above the Medical Devices & Instruments median (#326 of 851)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
89GF Score
Get the complete analysis for VMD
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
